cor2ed
engage checkpoint medical linkedin twitter
bg

How do we identify and treat patients with BRAF-mutated mCRC?

How do we identify and treat patients with BRAF-mutated mCRC?

Asst. Prof. Joleen Hubbard, Prof. Armin Gerger

Dr. Scott Kopetz (USA) led a very interesting and interactive GI CONNECT virtual Experts Knowledge Share which addressed the question ‘How do we identify and treat patients with BRAF-mutated mCRC (metastatic colorectal cancer) today and tomorrow?' Dr. Armin Gerger and Dr. Joleen Hubbard provided the US and European perspectives on this important topic.
Portrait of Joleen Hubbard
Asst. Prof. Joleen Hubbard

Medical Oncologist

Mayo Cinic Rochester

United States (US)

Portrait of Armin Gerger
Prof. Armin Gerger

Medical Oncologist

Medical University of Vienna

Austria

preview next

time | open 5 min | Oct 2020

download resources

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Other programmes developed by Asst. Prof. Joleen Hubbard

Other programmes developed by Prof. Armin Gerger